Drawing for PHARMULATOR

USPTO serial 79303409

PHARMULATOR

Reviewed by CopyMark Law Group

Reg. 6617249Status 700Registered
Filing date
Status date
Registration date
Jan 18, 2022
Examiner
LIEBL, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMULATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.400 East Van Buren Street, Suite 1900One Arizona CenterPhoenix, AZ 85004-2202

Goods and services

ClassDescriptionStatusFirst use
042Design and development of virtual reality software; scientific and technological services, namely, scientific research; scientific laboratory services; protein chemical analysis; product development of devices for protein analysis; new product design services, namely, design of devices intended for protein analysis; database design and development; scientific research conducted using databases; biological analysis of molecular anatomy; product development of devices for molecular analysis; development of computer software for big data processing; technical consulting services in the field of data analysis for biotechnological applications; technical consulting services in the field of computer software development for biotechnological applications; research in the field of biotechnology; biochemical analysis; software as a service (SAAS) services featuring software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; platform as a service (PAAS) featuring computer software platforms for software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; technical support services, namely, providing technical advice in the field of drug discovery for providing artificial intelligence based computer software; drug discovery services; research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; technical consultancy relating to pharmaceutical research and development; clinical trials in medicines for others; hosting an online website featuring medical information; design of medical diagnostic apparatus and instruments; computer services, namely, computer system administration for others for remote data management of medical diagnostic instruments; technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; research for medical products; technical consulting services in the field of testing, inspection, and research of medical products; research and development of computer software platforms in the field of artificial intelligence; development of computer software for artificial intelligence services; scientific research, namely, conducting clinical trials for others; updating and maintenance of computer software; drug discovery services through a method of computer modeling; rental of computer programs of computer simulation; chemical analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 29, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 28, 2022FIMPFINAL DISPOSITION PROCESSED—
Apr 18, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 18, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 18, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 13, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 20, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2021RFRRREFUSAL PROCESSED BY MPU—
May 28, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2021DOCKASSIGNED TO EXAMINER—
Feb 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance